Chapter 51: Managing Female Reproductive Disorders

Managing Female Reproductive Disorders professional and comprehensive chapter outlines the management of patients experiencing female reproductive disorders, covering infections, structural abnormalities, and benign and malignant conditions. Discussion begins with vulvovaginal health, emphasizing the normal vaginal ecosystem maintained by Lactobacillus acidophilus and the subsequent increase in infection risk when the vaginal pH balance is altered. Specific common infections reviewed include candidiasis (yeast), typically presenting with a white, cheeselike discharge and treated with antifungals, and bacterial vaginosis, characterized by an overgrowth of anaerobic bacteria and a noticeable fishlike odor, managed with metronidazole. The chapter covers prevalent sexually transmitted infections (STIs) such as trichomoniasis, a protozoan infection requiring simultaneous treatment of sexual partners, and Human Papillomavirus (HPV), which is linked to condylomata and high-risk dysplasia that can progress to cervical cancer, underscoring the importance of vaccination. Genital herpes (HSV-2), a lifelong viral infection, is managed through symptomatic relief and antiviral agents like acyclovir to suppress recurrence. The inflammatory condition known as Pelvic Inflammatory Disease (PID), often a severe complication of untreated chlamydia or gonorrhea, is detailed, with medical treatment focusing on broad-spectrum antibiotics to mitigate long-term consequences such as ectopic pregnancy and infertility. Structural disorders addressed include pelvic organ prolapse, such as cystocele (bladder displacement) and rectocele (rectal bulging). Management strategies range from nonsurgical measures like Kegel exercises and the use of vaginal pessaries for support, to surgical repairs like colporrhaphy. Benign conditions discussed include Polycystic Ovary Syndrome (PCOS), a hormonal imbalance involving chronic anovulation and hyperandrogenism, treated primarily through lifestyle modification and hormonal therapy. Uterine fibroids (myomas), which are common benign muscle tumors, may be managed conservatively or surgically through myomectomy or advanced noninvasive techniques such as Magnetic resonance-guided focused ultrasound surgery (MRgFUS) or uterine artery embolization (UAE). Endometriosis, involving ectopic endometrial tissue, is a leading cause of chronic pelvic pain and infertility, managed with hormonal suppression or definitive surgical removal. Finally, the chapter addresses gynecologic malignancies, noting that ovarian cancer is the leading cause of death among these cancers and is often diagnosed at advanced stages, requiring extensive surgery and platinum-based chemotherapy. Uterine and cervical cancers are also reviewed, emphasizing the role of Pap smears for early detection and the use of surgery, chemotherapy, and radiation therapy, including internal brachytherapy. Nursing care is synthesized throughout the chapter, detailing assessment protocols and interventions focused on managing pain, reducing anxiety, promoting positive body image, and preventing critical postoperative complications like venous thromboembolism (VTE) and hemorrhage, particularly following surgical procedures such as hysterectomy.